EVLO - エベロ・バイオサイエンシズ (Evelo Biosciences Inc.) エベロ・バイオサイエンシズ

 EVLOのチャート


 EVLOの企業情報

symbol EVLO
会社名 Evelo Biosciences Inc (エベロ・バイオサイエンシズ)
分野(sector) Health Care   ヘルスケア
産業(industry) Major Pharmaceuticals  
業種 バイオテクノロジ―_メディカルリサ―チ   医療関連(Health Care)
概要 事業概要 Evelo Biosciences Inc. is engaged in developing therapies designed to act on gut-body network. The Company develops monoclonal microbes that are orally-delivered compositions of specific strains of naturally occurring microbes derived from a single clone. Its principal product candidates include EDP1066 EDP1815 and EDP1503 that are in the pre-clinical development stage. EDP1066 and EDP1815 are monoclonal microbial product candidates that are developed to treat inflammatory diseases that include psoriasis atopic dermatitis rheumatoid arthritis and ulcerative colitis. EDP1503 is the Company's product candidate developed under oncology portfolio to treat diseases such as colorectal cancer renal cell carcinoma and melanoma among others.   エベロ・バイオサイエンシズは米国のバイオ医薬品企業。主にマイクロバイオ―ムによる、がん、自己免疫および炎症性疾患に対する免疫療法の開発に従事する。同社は、がん治療のためのオンコマイシンを開発。また、アトピ―性皮膚炎、関節リウマチ、潰瘍性大腸炎、結腸直腸がん、腎細胞がん、メラノ―マなどの免疫療法に焦点を当てる。本社所在地はマサチュ―セッツ州ケンブリッジ。   
本社所在地 620 Memorial Drive Suite 200 Cambridge MA 02139 USA
代表者氏名 Noubar B. Afeyan Noubar B. Afeyan
代表者役職名 Chairman of the Board 取締役会会長
電話番号 +1 617-870-8281
設立年月日 41760
市場名 NASDAQ National Market System
ipoyear 2018年
従業員数 59人
url www.evelobio.com
nasdaq_url https://www.nasdaq.com/symbol/evlo
adr_tso
EBITDA EBITDA(百万ドル) ー
終値(lastsale) 11.65
時価総額(marketcap) 369789663.3
時価総額 時価総額(百万ドル) 360.26720
売上高 売上高(百万ドル) --
企業価値(EV) 企業価値(EV)(百万ドル) 196.11820
当期純利益 当期純利益(百万ドル) --
決算概要 決算概要 BRIEF: For the six months ended 30 June 2018 Evelo Biosciences Inc revenues was not reported. Net loss applicable to common stockholders increased from $14.4M to $29.6M. Higher net loss reflects Research and development - Balancing increase of 96% to $16.3M (expense) General and administrative - Balancing increase from $2.6M to $6.4M (expense) Stock-based Compensation in SGA increase from $256K to $1.9M (expense).

 EVLOのテクニカル分析


 EVLOのニュース

   The Daily Biotech Pulse: Sorrento, Immutep Surge On COVID-19 Study Data, T2 Biosystems Sinks On Preannouncement  2021/01/27 12:35:59 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Jan. 26) Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN ) Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY ) Aslan Pharmaceuticals Ltd (NASDAQ: ASLN ) (reacted to new preclinical data showing its investigational asset ASLAN003 have the lowest potential for hepatotoxicity) BIOLASE Inc (NASDAQ: BIOL ) (reacted to its preliminary fourth-quarter results) BioNano Genomics Inc (NASDAQ: BNGO ) CASI Pharmaceuticals Inc (NASDAQ: CASI ) Cassava Sciences Inc (NASDAQ: SAVA ) Clearpoint Neuro Inc (NASDAQ: CLPT ) Cleveland BioLabs, Inc. (NASDAQ: CBLI ) DarioHealth Corp (NASDAQ: DRIO ) DermTech Inc (NASDAQ: DMTK ) Eli Lilly And Co (NYSE: LLY ) (reacted to positive data for its monoclonal antibody cocktail in treating COVID-19) ENDRA Life Sciences Inc (NASDAQ: NDRA ) ESSA Pharma Inc (NASDAQ: EPIX ) Evelo Biosciences Inc (NASDAQ: EVLO ) Evogene Ltd (NASDAQ: EVGN ) GW Pharmaceuticals PLC- ADR (NASDAQ: GWPH ) Illumina, Inc.
   The Daily Biotech Pulse: Bausch Health Issues Positive Pre-Announcement, Acorda Streamlines Operations  2021/01/13 12:25:38 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Jan. 12) AbbVie Inc (NYSE: ABBV ) AcelRx Pharmaceuticals Inc (NASDAQ: ACRX ) Aldeyra Therapeutics Inc (NASDAQ: ALDX ) Alkermes Plc (NASDAQ: ALKS ) AtriCure Inc. (NASDAQ: ATRC ) Bioanalytical Systems, Inc. (NASDAQ: BASI ) BIOLASE Inc (NASDAQ: BIOL ) (announced an agreement to expand laser adoption and hands-on training programs in targeted geographies) CareDx Inc (NASDAQ: CDNA ) Celsius Holdings, Inc. (NASDAQ: CELH ) DermTech Inc (NASDAQ: DMTK ) Dyne Therapeutics Inc (NASDAQ: DYN ) Edap Tms SA (NASDAQ: EDAP ) Evelo Biosciences Inc (NASDAQ: EVLO ) EXACT Sciences Corporation (NASDAQ: EXAS ) Eyenovia Inc (NASDAQ: EYEN ) Genetron Holdings Ltd – ADR (NASDAQ: GTH ) Guardant Health Inc (NASDAQ: GH ) (reacted to presentation at the JPMorgan Healthcare Conference) Intra-Cellular Therapies Inc (NASDAQ: ITCI ) Kaleido Biosciences Inc (NASDAQ: KLDO ) Laboratory Corp.
   Flagship Pioneering Unveils Pioneering Medicines  2021/01/12 15:00:00 Benzinga
CAMBRIDGE, Mass. , Jan. 12, 2021 /PRNewswire/ -- Flagship Pioneering, a life science platforms company, today unveiled Pioneering Medicines, a new division of Flagship Pioneering. Initiated in 2020, Pioneering Medicines' mandate is to build a world-class biopharmaceutical R&D capability to conceive and develop a broad portfolio of life-changing treatments for patients. By harnessing the power of Flagship's multiple scientific platforms, Pioneering Medicines will create and advance novel medicines that deliver benefits to more patients, sooner. Delivering Benefits to More Patients, Sooner Across the Flagship ecosystem, more than 40 companies are creating and applying innovative approaches to help address major health and sustainability issues. Many of these Flagship platforms including RNA-based approaches such as Moderna and Omega Therapeutics , gene-based therapeutic approaches such as Sana Biotechnology , Tessera Therapeutics and Ring Therapeutics , cell therapy approaches such as Rubius Therapeutics and Sigilon Therapeutics , machine learning approaches such as Valo , Generate Biomedicines and Cellarity , and microbiome-related approaches such as Seres Therapeutics , Kaleido Biosciences and Evelo Biosciences , have broad applicability.
   The Daily Biotech Pulse: FDA Nod For Amphastar's Generic Glucagon, Arcturus Sinks On Vaccine Data, Decision Day For Osmotica  2020/12/29 13:09:37 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Dec. 28) Aclaris Therapeutics Inc (NASDAQ: ACRS ) Allakos Inc (NASDAQ: ALLK ) Apellis Pharmaceuticals Inc (NASDAQ: APLS ) Arvinas Inc (NASDAQ: ARVN ) Atea Pharmaceuticals, Inc. (NASDAQ: AVIR ) AtriCure Inc. (NASDAQ: ATRC ) BIO-TECHNE Corp (NASDAQ: TECH ) BridgeBio Pharma Inc (NASDAQ: BBIO ) Cellectis SA (NASDAQ: CLLS ) Crispr Therapeutics AG (NASDAQ: CRSP ) Curis, Inc. (NASDAQ: CRIS ) Edwards Lifesciences Corp (NYSE: EW ) ESSA Pharma Inc (NASDAQ: EPIX ) Eton Pharmaceuticals Inc (NASDAQ: ETON ) Evelo Biosciences Inc (NASDAQ: EVLO ) Evogene Ltd (NASDAQ: EVGN ) Inari Medical Inc (NASDAQ: NARI ) Integra Lifesciences Holdings Corp (NASDAQ: IART ) Intellia Therapeutics Inc (NASDAQ: NTLA ) Jazz Pharmaceuticals PLC (NASDAQ: JAZZ ) Kodiak Sciences Inc (NASDAQ: KOD ) Kymera Therapeutics Inc (NASDAQ: KYMR ) Lumos Pharma Inc (NASDAQ: LUMO ) Medicenna Therapeutics Corp (NASDAQ: MDNA ) Myovant Sciences Ltd (NYSE: MYOV ) - announced a licensing deal with Pfizer Inc.
   Thinking about buying stock in OncoCyte, FuelCell Energy, Evelo Biosciences, Lydall, or Prevail Therapeutics?  2020/12/15 15:50:00 PR Newswire
NEW YORK, Dec. 15, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for OCX, FCEL, EVLO, LDL, and PRVL. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link….
   The Daily Biotech Pulse: FDA Nod For Amphastar's Generic Glucagon, Arcturus Sinks On Vaccine Data, Decision Day For Osmotica  2020/12/29 13:09:37 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Dec. 28) Aclaris Therapeutics Inc (NASDAQ: ACRS ) Allakos Inc (NASDAQ: ALLK ) Apellis Pharmaceuticals Inc (NASDAQ: APLS ) Arvinas Inc (NASDAQ: ARVN ) Atea Pharmaceuticals, Inc. (NASDAQ: AVIR ) AtriCure Inc. (NASDAQ: ATRC ) BIO-TECHNE Corp (NASDAQ: TECH ) BridgeBio Pharma Inc (NASDAQ: BBIO ) Cellectis SA (NASDAQ: CLLS ) Crispr Therapeutics AG (NASDAQ: CRSP ) Curis, Inc. (NASDAQ: CRIS ) Edwards Lifesciences Corp (NYSE: EW ) ESSA Pharma Inc (NASDAQ: EPIX ) Eton Pharmaceuticals Inc (NASDAQ: ETON ) Evelo Biosciences Inc (NASDAQ: EVLO ) Evogene Ltd (NASDAQ: EVGN ) Inari Medical Inc (NASDAQ: NARI ) Integra Lifesciences Holdings Corp (NASDAQ: IART ) Intellia Therapeutics Inc (NASDAQ: NTLA ) Jazz Pharmaceuticals PLC (NASDAQ: JAZZ ) Kodiak Sciences Inc (NASDAQ: KOD ) Kymera Therapeutics Inc (NASDAQ: KYMR ) Lumos Pharma Inc (NASDAQ: LUMO ) Medicenna Therapeutics Corp (NASDAQ: MDNA ) Myovant Sciences Ltd (NYSE: MYOV ) - announced a licensing deal with Pfizer Inc.
   Thinking about buying stock in OncoCyte, FuelCell Energy, Evelo Biosciences, Lydall, or Prevail Therapeutics?  2020/12/15 15:50:00 PR Newswire
NEW YORK, Dec. 15, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for OCX, FCEL, EVLO, LDL, and PRVL. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link….
   Evelo Biosciences Earnings Report: Here’s what to expect from Stock market Insights & financial analysis  2020/10/29 19:44:00 Stock Market Daily
Evelo Biosciences announce their quarterly, annual earnings. See the latest EPS estimates. Listen to the conference call and remind yourself by…
   Earnings Scheduled For October 29, 2020  2020/10/29 08:08:21 Benzinga
Companies Reporting Before The Bell • PG&E (NYSE: PCG ) is likely to report quarterly earnings at $0.27 per share on revenue of $4.72 billion. • Silicom (NASDAQ: SILC ) is estimated to report quarterly earnings at $0.35 per share on revenue of $26.68 million. • Ambev (NYSE: ABEV ) is expected to report quarterly earnings at $0.02 per share on revenue of $2.28 billion. • Ares Commercial Real (NYSE: ACRE ) is estimated to report quarterly earnings at $0.24 per share on revenue of $17.15 million. • Alliance Data Systems (NYSE: ADS ) is expected to report quarterly earnings at $2.20 per share on revenue of $1.01 billion. • Agenus (NASDAQ: AGEN ) is expected to report quarterly loss at $0.26 per share on revenue of $14.00 million. • Alexion Pharmaceuticals (NASDAQ: ALXN ) is projected to report quarterly earnings at $2.58 per share on revenue of $1.42 billion. • AMETEK (NYSE: AME ) is estimated to report quarterly earnings at $0.93 per share on revenue of $1.11 billion. • Amerant Bancorp (NASDAQ: AMTB ) is projected to report quarterly earnings at $0.
   Evelo Biosciences to Report Third Quarter 2020 Financial Results on Thursday, October 29, 2020  2020/10/22 20:01:00 GlobeNewswire
CAMBRIDGE, Mass., Oct. 22, 2020 (GLOBE NEWSWIRE) -- Evelo Biosciences (Nasdaq:EVLO), a clinical stage biotechnology company developing a new modality of…
   Thinking about buying stock in OncoCyte, FuelCell Energy, Evelo Biosciences, Lydall, or Prevail Therapeutics?  2020/12/15 15:50:00 PR Newswire
NEW YORK, Dec. 15, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for OCX, FCEL, EVLO, LDL, and PRVL. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link….
   Evelo Biosciences Earnings Report: Here’s what to expect from Stock market Insights & financial analysis  2020/10/29 19:44:00 Stock Market Daily
Evelo Biosciences announce their quarterly, annual earnings. See the latest EPS estimates. Listen to the conference call and remind yourself by…
   Earnings Scheduled For October 29, 2020  2020/10/29 08:08:21 Benzinga
Companies Reporting Before The Bell • PG&E (NYSE: PCG ) is likely to report quarterly earnings at $0.27 per share on revenue of $4.72 billion. • Silicom (NASDAQ: SILC ) is estimated to report quarterly earnings at $0.35 per share on revenue of $26.68 million. • Ambev (NYSE: ABEV ) is expected to report quarterly earnings at $0.02 per share on revenue of $2.28 billion. • Ares Commercial Real (NYSE: ACRE ) is estimated to report quarterly earnings at $0.24 per share on revenue of $17.15 million. • Alliance Data Systems (NYSE: ADS ) is expected to report quarterly earnings at $2.20 per share on revenue of $1.01 billion. • Agenus (NASDAQ: AGEN ) is expected to report quarterly loss at $0.26 per share on revenue of $14.00 million. • Alexion Pharmaceuticals (NASDAQ: ALXN ) is projected to report quarterly earnings at $2.58 per share on revenue of $1.42 billion. • AMETEK (NYSE: AME ) is estimated to report quarterly earnings at $0.93 per share on revenue of $1.11 billion. • Amerant Bancorp (NASDAQ: AMTB ) is projected to report quarterly earnings at $0.
   Evelo Biosciences to Report Third Quarter 2020 Financial Results on Thursday, October 29, 2020  2020/10/22 20:01:00 GlobeNewswire
CAMBRIDGE, Mass., Oct. 22, 2020 (GLOBE NEWSWIRE) -- Evelo Biosciences (Nasdaq:EVLO), a clinical stage biotechnology company developing a new modality of…
   Evelo Biosciences Announces Proposed Public Offering of Common Stock  2020/06/24 20:01:00 GlobeNewswire
CAMBRIDGE, Mass., June 24, 2020 (GLOBE NEWSWIRE) -- Evelo Biosciences, Inc. (Nasdaq: EVLO) (“Evelo”), a clinical stage biotechnology company developing a…

 関連キーワード  (バイオテクノロジ―_メディカルリサ―チ 米国株 エベロ・バイオサイエンシズ EVLO Evelo Biosciences Inc.)

 twitter  (公式ツイッターやCEOツイッターなど)